 Administration, Inhalation
"Administration, Inhalation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract.
| Descriptor ID |
D000280
|
| MeSH Number(s) |
E02.319.267.050
|
| Concept/Terms |
Administration, Inhalation- Administration, Inhalation
- Respiratory Drug Administration
- Inhalation Drug Administration
- Drug Administration, Respiratory
- Administration, Respiratory Drug
- Inhalation Administration
- Drug Administration, Inhalation
- Administration, Inhalation Drug
Drug Aerosol Therapy- Drug Aerosol Therapy
- Drug Therapy, Aerosol
- Aerosol Drug Therapy
- Therapy, Aerosol Drug
- Aerosol Therapy, Drug
- Therapy, Drug Aerosol
|
Below are MeSH descriptors whose meaning is more general than "Administration, Inhalation".
Below are MeSH descriptors whose meaning is more specific than "Administration, Inhalation".
This graph shows the total number of publications written about "Administration, Inhalation" by people in UAMS Profiles by year, and whether "Administration, Inhalation" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 0 | 1 | 1 | | 2023 | 0 | 2 | 2 | | 2022 | 0 | 3 | 3 | | 2021 | 0 | 4 | 4 | | 2020 | 2 | 3 | 5 | | 2019 | 0 | 1 | 1 | | 2018 | 0 | 1 | 1 | | 2017 | 1 | 5 | 6 | | 2016 | 0 | 3 | 3 | | 2015 | 0 | 8 | 8 | | 2014 | 0 | 3 | 3 | | 2013 | 0 | 4 | 4 | | 2012 | 0 | 7 | 7 | | 2011 | 0 | 2 | 2 | | 2010 | 0 | 5 | 5 | | 2007 | 0 | 1 | 1 | | 2006 | 0 | 4 | 4 | | 2005 | 0 | 3 | 3 | | 2004 | 0 | 5 | 5 | | 2003 | 0 | 1 | 1 | | 2002 | 0 | 2 | 2 | | 2001 | 0 | 4 | 4 | | 2000 | 0 | 3 | 3 | | 1999 | 1 | 0 | 1 | | 1998 | 0 | 2 | 2 | | 1997 | 0 | 4 | 4 | | 1996 | 0 | 1 | 1 | | 1993 | 0 | 1 | 1 | | 1990 | 0 | 1 | 1 | | 1989 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Administration, Inhalation" by people in Profiles over the past ten years.
-
Saad D, Spray BJ, Pertzborn MC. Identifying disparities in pediatric cystic fibrosis care between low-middle and middle-high income countries in the Middle East. Respir Med. 2024 Nov-Dec; 234:107821.
-
Patrick KC, Spray BJ, Pertzborn MC. Impact of Post-Visit Outreach on Inhaled Corticosteroid Refill Persistence in Children and Young Adults With Asthma. Respir Care. 2023 11; 68(11):1540-1545.
-
Guo Y, Bian J, Chen Z, Fishe JN, Zhang D, Braithwaite D, George TJ, Shenkman EA, Licht JD. Cancer incidence after asthma diagnosis: Evidence from a large clinical research network in the United States. Cancer Med. 2023 05; 12(10):11871-11877.
-
Berlinski A. Changing Positions When New Data Are Available Is Essential to Science: A Tale of a Breath-Enhanced Nebulizer. Respir Care. 2022 08; 67(8):1064-1065.
-
Yates AR, Berger JT, Reeder RW, Banks R, Mourani PM, Berg RA, Carcillo JA, Carpenter T, Hall MW, Meert KL, McQuillen PS, Pollack MM, Sapru A, Notterman DA, Holubkov R, Dean JM, Wessel DL. Characterization of Inhaled Nitric Oxide Use for Cardiac Indications in Pediatric Patients. Pediatr Crit Care Med. 2022 04 01; 23(4):245-254.
-
Sharma M, Callan E, Konduri GG. Pulmonary Vasodilator Therapy in Persistent Pulmonary Hypertension of the Newborn. Clin Perinatol. 2022 03; 49(1):103-125.
-
Nelin L, Kinsella JP, Courtney SE, Pallotto EK, Tarau E, Potenziano JL. Use of inhaled nitric oxide in preterm vs term/near-term neonates with pulmonary hypertension: results of the PaTTerN registry study. J Perinatol. 2022 01; 42(1):14-18.
-
Maddux AB, Mourani PM, Banks R, Reeder RW, Pollack MM, Berg RA, Meert KL, McQuillen PS, Yates AR, Notterman DA, Berger JT. Inhaled Nitric Oxide Use and Outcomes in Critically Ill Children With a History of Prematurity. Respir Care. 2021 Oct; 66(10):1549-1559.
-
Qaqish R, Berlinski A. Effects of Shake-Actuation Delay on Delivered Dose and Aerosol Characteristics of an Albuterol Suspension From a Pressurized Metered-Dose Inhaler. Respir Care. 2021 Aug; 66(8):1315-1322.
-
Berlinski A. In Vitro Comparison of Different Nebulizers Delivering 7% Hypertonic Saline. Respir Care. 2021 Oct; 66(10):1582-1587.
-
Berger JT, Maddux AB, Reeder RW, Banks R, Mourani PM, Berg RA, Carcillo JA, Carpenter T, Hall MW, Meert KL, McQuillen PS, Pollack MM, Sapru A, Yates AR, Notterman DA, Holubkov R, Dean JM, Wessel DL. Inhaled Nitric Oxide Use in Pediatric Hypoxemic Respiratory Failure. Pediatr Crit Care Med. 2020 08; 21(8):708-719.
-
Bagwell T, Hollingsworth A, Thompson T, Abramo T, Huckabee M, Chang D, Crawley L, Robbins JM. Management of Croup in the Emergency Department: The Role of Multidose Nebulized Epinephrine. Pediatr Emerg Care. 2020 Jul; 36(7):e387-e392.
-
Mitchell JP, Berlinski A, Canisius S, Cipolla D, Dolovich MB, Gonda I, Hochhaus G, Kadrichu N, Lyapustina S, Mansour HM, Darquenne C, Clark AR, Newhouse M, Ehrmann S, Humphries R, Boushey H. Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Statement from the ISAM Regulatory and Standardization Issues Networking Group. J Aerosol Med Pulm Drug Deliv. 2020 08; 33(4):235-238.
-
Berlinski A. 2019 Year in Review: Aerosol Therapy. Respir Care. 2020 May; 65(5):705-712.
-
Pertzborn MC, Prabhakaran S, Abu-Hasan M, Baker D, Wu S, Wu Y, Hendeles L. Continuous Albuterol With Benzalkonium in Children Hospitalized With Severe Asthma. Pediatrics. 2020 04; 145(4).
-
McKinzie CJ, Chen L, Ehlert K, Grisso AG, Linafelter A, Lubsch L, O'Brien CE, Pan AC, Wright BA, Elson EC. Off-label use of intravenous antimicrobials for inhalation in patients with cystic fibrosis. Pediatr Pulmonol. 2019 11; 54 Suppl 3:S27-S45.
-
Awad SM, Berlinski A. Crossover Evaluation of Compressors and Nebulizers Typically Used by Cystic Fibrosis Patients. Respir Care. 2018 Mar; 63(3):294-300.
-
Berlinski A, von Hollen D, Pritchard JN, Hatley RH. Delay Between Shaking and Actuation of a Hydrofluoroalkane Fluticasone Pressurized Metered-Dose Inhaler. Respir Care. 2018 Mar; 63(3):289-293.
-
Velasco J, Berlinski A. Albuterol Delivery Efficiency in a Pediatric Model of Noninvasive Ventilation With Double-Limb Circuit. Respir Care. 2018 Feb; 63(2):141-146.
-
Berlinski A, Pennington D. Effect of Interval Between Actuations of Albuterol Hydrofluoroalkane Pressurized Metered-Dose Inhalers on Their Aerosol Characteristics. Respir Care. 2017 Sep; 62(9):1123-1130.
-
Berlinski A. Pediatric Aerosol Therapy. Respir Care. 2017 Jun; 62(6):662-677.
-
Keller RL, Eichenwald EC, Hibbs AM, Rogers EE, Wai KC, Black DM, Ballard PL, Asselin JM, Truog WE, Merrill JD, Mammel MC, Steinhorn RH, Ryan RM, Durand DJ, Bendel CM, Bendel-Stenzel EM, Courtney SE, Dhanireddy R, Hudak ML, Koch FR, Mayock DE, McKay VJ, Helderman J, Porta NF, Wadhawan R, Palermo L, Ballard RA. The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1-Year Corrected Age. J Pediatr. 2017 04; 183:19-25.e2.
-
Berlinski A, Ari A, Davies P, Fink J, Majaesic C, Reychler G, Tatla T, Amirav I. Workshop Report: Aerosol Delivery to Spontaneously Breathing Tracheostomized Patients. J Aerosol Med Pulm Drug Deliv. 2017 Aug; 30(4):207-222.
-
Berlinski A, von Hollen D, Hatley RHM, Hardaker LEA, Nikander K. Drug Delivery in Asthmatic Children Following Coordinated and Uncoordinated Inhalation Maneuvers: A Randomized Crossover Trial. J Aerosol Med Pulm Drug Deliv. 2017 Jun; 30(3):182-189.
-
Tadphale SD, Rettiganti M, Gossett JM, Beam BW, Padiyath A, Schmitz ML, Gupta P. Is Administration of Nitric Oxide During Extracorporeal Membrane Oxygenation Associated With Improved Patient Survival? Pediatr Crit Care Med. 2016 11; 17(11):1080-1087.
-
Berlinski A, Cooper B. Oronasal and Tracheostomy Delivery of Soft Mist and Pressurized Metered-Dose Inhalers With Valved Holding Chamber. Respir Care. 2016 Jul; 61(7):913-9.
-
Campbell CT, McCaleb R, Manasco KB. New Inhaled Antimicrobial Formulations for Use in the Cystic Fibrosis Patient Population. Ann Pharmacother. 2016 Feb; 50(2):133-40.
-
Ballard RA, Keller RL, Black DM, Ballard PL, Merrill JD, Eichenwald EC, Truog WE, Mammel MC, Steinhorn RH, Rogers EE, Ryan RM, Durand DJ, Asselin JM, Bendel CM, Bendel-Stenzel EM, Courtney SE, Dhanireddy R, Hudak ML, Koch FR, Mayock DE, McKay VJ, O'Shea TM, Porta NF, Wadhawan R, Palermo L. Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide. J Pediatr. 2016 Jan; 168:23-29.e4.
-
Mourani PM, Abman SH. Pulmonary Hypertension and Vascular Abnormalities in Bronchopulmonary Dysplasia. Clin Perinatol. 2015 Dec; 42(4):839-55.
-
Cooper B, Berlinski A. Albuterol Delivery via Facial and Tracheostomy Route in a Model of a Spontaneously Breathing Child. Respir Care. 2015 Dec; 60(12):1749-58.
-
Berlinski A. Assessing New Technologies in Aerosol Medicine: Strengths and Limitations. Respir Care. 2015 Jun; 60(6):833-47; discussion 847-9.
-
Berlinski A, Willis JR. Effect of Tidal Volume and Nebulizer Type and Position on Albuterol Delivery in a Pediatric Model of Mechanical Ventilation. Respir Care. 2015 Oct; 60(10):1424-30.
-
Todd Tzanetos DR, Housley JJ, Barr FE, May WL, Landers CD. Implementation of an inhaled nitric oxide protocol decreases direct cost associated with its use. Respir Care. 2015 May; 60(5):644-50.
-
El Taoum KK, Xi J, Kim J, Berlinski A. In Vitro Evaluation of Aerosols Delivered via the Nasal Route. Respir Care. 2015 Jul; 60(7):1015-25.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|